Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...

Novo Nordisk NVO and Aspect Biosystems announced that they are advancing their partnership into a new phase focused on ...

A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a first-in-class chemical inhibitor that precisely and selectively targets the ATAC ...

By selectively blocking the ATAC complex via its unique YEATS2 subunit, a new inhibitor turns off tumor-promoting genes, ...

How One Tiny Cellular Structure Holds the Key to Better Health & Longevity — and How You Can Harness It ...

It’s tried repurposing a platform from its internal-combustion cars (for the EX40 and EC40, nee XC40 Recharge and C40 ...

Researchers developed LS-170, an inhibitor of the ATAC complex, which suppressed oncogene expression and reduced tumor growth ...

The third week under the Gold Dome proved much busier on the legislation side of things, with appropriations week in the rearview mirror.

By simplifying the organization and placing creative and financial accountability closer to where value is created, the Group ...

The interdisciplinary collaboration was led by Professor Xiang David LI (HKU Chemistry), together with Professor Weiping WANG (HKU Pharmacology and Pharmacy), Researcher Xin LI (Shenzhen Bay ...